EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database ,

ISSN 2394-3211

Impact Factor: 6.222

ICV - 79.57

Abstract

AN UNUSUAL CASE OF TUBERCULAR NEURORETINITIS AND JUXTAPAPILLARY CHOROIDITIS

Dr. Himanshi Bhardwaj, Dr. Richa Sharma, Dr. Nagesh Pandit* and Dr. Gaurav Sharma

ABSTRACT

OTB still represents a major diagnostic and therapeutic challenge, due to its heterogeneous clinical manifestations, mixed ocular tissue involvement, lack of diagnostic criteria and gold standard tests, and lack of international agreement on the therapeutic approach. We report a rare case of patient with tuberculous neuroretinitis and atypical juxtapapillary choroiditis who responded to antituberculosis treatment (ATT) and systemic corticosteroid with complete recovery of vision.

Keywords: choroiditis, neuroretinitis, juxtapapillary, corticosteroids.

[Full Text Article]

SJIF Impact Factor: 6.222

INDEXING

Indexing

LOGIN

NEWS & UPDATION

EJPMR: JUNE ISSUE PUBLISHED
JUNE issue has been successfully launched on 1 JUNE 2023.

New Issue Published
Its Our pleasure to inform you that, EJPMR 1 June 2023 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

EJPMR New Impact Factor
Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from 5.804 to 6.222, due to high quality Publication at International Level